<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823981/" ref="ordinalpos=2581&amp;ncbi_uid=2788433&amp;link_uid=PMC2823981" image-link="/pmc/articles/PMC2823981/figure/F5/" class="imagepopup">Figure 5. Major mechanisms proposed to regulate hormone-dependent transformation in some tumors.  From: RSK in Tumorigenesis: Connections to Steroid <span class="highlight" style="background-color:">Signaling</span>. </a></div><br /><div class="p4l_captionBody">Estrogens stimulate ERα complex formation with cytoplasmic signaling proteins like MNAR, cas, and c-SRC. This complex activates the ERK1/2 signal transduction pathway, and phosphorylation of RSK. RSK1 signaling inhibits apoptosis via phosphorylation and inactivation of the pro-apoptotic protein Bad. RSK2 can translocate to the nucleus where it regulates nuclear targets that drive proliferation. In the nucleus RSK directly phosphorylates ERα stimulating its transcriptional activity.</div></div>